Cargando…
Differential diagnostic CYFRA 21-1 level for benign and malignant pleural effusions: a meta-analysis in the Chinese population
INTRODUCTION: Many studies have investigated the usefulness of cytokeratin 19 fragments (CYFRA 21-1) in pleural fluid for the differential diagnosis of benign (BPE) and malignant pleural (MPE) effusions. In the present meta-analysis, the reported studies on the diagnosis between CYFRA 21-1 and pleur...
Autores principales: | Biaoxue, Rong, Shuanying, Yang, Xiguang, Cai, Wei, Zhang, Wei, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3506225/ https://www.ncbi.nlm.nih.gov/pubmed/23185183 http://dx.doi.org/10.5114/aoms.2012.30831 |
Ejemplares similares
-
Thoracic perfusion of recombinant human endostatin (Endostar) combined with chemotherapeutic agents versus chemotherapeutic agents alone for treating malignant pleural effusions: a systematic evaluation and meta-analysis
por: Biaoxue, Rong, et al.
Publicado: (2016) -
Thoracic perfusion of matrine as an adjuvant treatment improves the control of the malignant pleural effusions
por: Biaoxue, Rong, et al.
Publicado: (2015) -
Evaluation of pleural CYFRA 21-1 and carcinoembryonic antigen in the diagnosis of malignant pleural effusions.
por: Salama, G., et al.
Publicado: (1998) -
Evaluation of serum cyfra21 in patients with pleural effusion
por: Azimi, Q, et al.
Publicado: (2012) -
Evaluation of efficacy and safety for recombinant human adenovirus-p53 in the control of the malignant pleural effusions via thoracic perfusion
por: Biaoxue, Rong, et al.
Publicado: (2016)